Caricamento...
Tissue is the issue and tissue competition. Re-biopsy for mutation T790: where and why?
Lung cancer is still the leading cause of death among all cancers. During the last 15 years, pharmacogenomics of lung cancer have established targeted therapy with tyrosine kinase inhibitors (TKIs) for epidermal growth factor receptor (EGFR) positive patients in adenocarcinoma or mixed adenosquamus...
Salvato in:
| Pubblicato in: | Clin Transl Med |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Springer Berlin Heidelberg
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5243233/ https://ncbi.nlm.nih.gov/pubmed/28101783 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40169-017-0135-8 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|